ORMP ORAMED PHARMACEUTICALS INC Company Mergers 8-K Filing 2023 - Stock Purchase Agreement Oramed Pharmaceuticals Inc. has entered into a Stock Purchase Agreement with Sorrento Therapeutics to acquire certain equity securities of Scilex Holding Company for a total purchase price of $105 million. The Seller and Scintilla Pharmaceuticals are in Chapter 11 bankruptcy proceedings.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC